Accelerating Breakthroughs in Cancer Research
At Southern Research, we’re driven to advance cancer drug discovery through science that makes a difference. Our preclinical oncology services are built on deep expertise in tumor biology, immunology, and radiopharmacology—paired with advanced analytical platforms—to help you move confidently from early discovery toward clinical development.
What Sets Us Apart:
- Specialized expertise in Radiopharm and Biodistribution
- Deep understanding of the Tumor Microenvironment
- Advanced capabilities in Inflammation and Immune Crosstalk
- Cutting-edge techniques in Spatial Transcriptomics
- Expertise in Tumor Kinetics and Cellular Pathways
Hematological Cancer Research
We specialize in preclinical hematological cancer research, including leukemia, lymphoma, and myeloma. Leveraging advanced in vitro and in vivo models, our scientific team accelerates your therapeutic candidates through precise efficacy, safety, and pharmacodynamics assessments.
Gastrointestinal Cancer Research (Colorectal & Pancreatic)
Gastrointestinal cancers, such as colorectal and pancreatic, require specialized approaches due to their complexity and aggressiveness. Our comprehensive preclinical models effectively support your novel therapies, streamlining progression toward clinical trials.
Radiopharmaceutical & Biodistribution
Our radiopharmaceutical capabilities include advanced biodistribution studies crucial for tracking therapeutic efficacy and safety. These specialized services optimize the clinical potential of your oncology treatments.
Inflammation & Immune Crosstalk
Understanding inflammation and immune interactions within tumors is essential for therapeutic success. Our expert analyses of tumor-immune dynamics facilitate targeted therapy development, ensuring improved clinical outcomes.
Radiopharmaceutical Development & Biodistribution
Advance your oncology therapeutics with our precise radiopharmaceutical and biodistribution expertise. Validate therapeutic distribution accurately, enhancing safety and efficacy.
Tumor-Immune Microenvironment Analysis
Optimize therapeutic outcomes through advanced analyses of tumor-immune interactions, leveraging spatial transcriptomics and immune profiling for deeper biological insights.
Our Experts
Rebecca Boohaker, Ph.D.
Omar Moukha-Chafiq, Ph.D.
Ready to Advance Your Research?
Contact our experts today and explore how Southern Research can elevate your project.